877.92BMarket Cap113.76P/E (TTM)
942.350High922.100Low2.05MVolume937.010Open935.020Pre Close1.90BTurnover0.22%Turnover Ratio159.26P/E (Static)950.43MShares972.53052wk High64.74P/B875.96BFloat Cap513.10952wk Low4.86Dividend TTM948.31MShs Float972.530Historical High0.53%Div YieldTTM2.17%Amplitude5.287Historical Low929.112Avg Price1Lot Size
Eli Lilly and Co Stock Forum
Baird's optimism is driven by promising developments in Instil’s PD-L1xVEGF bispecific antibody, especially following positive data from peers like Akeso and Summit. Analysts believe this drug class has strong potentia...
FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis
Will the Sept curse come back to haunt us? Is it fading away? Or there will be a bull party instead? Nothing is for sure. Next week will likely be volatile entering the rate cut week.
Another day of profit from yesterday. Nice.
$Broadcom (AVGO.US)$ $NVIDIA (NVDA.US)$ $Alphabet-A (GOOGL.US)$ $Eli Lilly and Co (LLY.US)$ $Tesla (TSLA.US)$
LLY projected revenue next year is 59B
PFE last year's revenue is already 58B
LLY is close to 1T market value
PFE is 1/6 MV, 165B market value
it's either PFE is extremely undervalued or LLY is ridiculously overvalued!
This is what I call the final plunge. Just like before a ship sinks, its hull will tilt out of the water to let all the air out and then sink like a rock !
But I think it's a bait and switch. I think we will close below 900 today.
Investing in $Eli Lilly and Co (LLY.US)$ with a long-term perspective, rather than trying to time the market, allows for benefiting from the company's consistent growth and innovation over time.
This approach helps ride out market fluctuations and capitalize on the company’s o...
No comment yet